SEC Form 4 · accession 0001626533-17-000019
Cell MedX Corp. · CMXC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Frank McEnulty
Officer — President, CEO · Director
Period of report
Oct 12, 2017
Accepted (ET)
Oct 18, 2017 · 3:36 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001493712
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Oct 12, 2017 | P | 481,016 | $0.25 | A | 481,016 | D |
Table II — derivative securities
No Table II lines on this filing.